Our immunohistochemistry analysis of lung tissues of COVID-19 patients revealed heightened levels of VE-cadherin in both lung stroma and blood vessels along with a reduced expression of β-catenin in COVID-19 patients compared with healthy controls (Figure 2). This evidence concerns the gene CDH5 and COVID-19.